Herpesviruses: A cofactor in the pathogenesis of idiopathic pulmonary fibrosis?

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 5 33-5, 2005, Pages

  Doran, Peter ^a   Egan, Jim J ^b  

^a Dublin Molecular Medicine Centre   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LATENT MEMBRANE PROTEIN 1; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; CELL DIFFERENTIATION; DISEASE COURSE; DISEASE PREDISPOSITION; EDITORIAL; EPSTEIN BARR VIRUS; EXTRACELLULAR MATRIX; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HERPES VIRUS; HUMAN; IDIOPATHIC DISEASE; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG FIBROSIS; LUNG FUNCTION; MURINE GAMMA HERPESVIRUS 68; NONHUMAN; PATHOGENESIS; PLEURA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TH2 CELL; TRANSBRONCHIAL BIOPSY; VIRUS REPLICATION;

ANIMALS; CYTOKINES; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MICE; PULMONARY FIBROSIS; RHADINOVIRUS;

EID: 27144503312     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00235.2005     Document Type: Editorial

References (14)

1. Ebrahimi B, Dutia BM, Brownstein DG, and Nash AA. Murine γ-herpes-virus 68 infection causes multiorgan fibrosis and alters leukocyte trafficking in interferon-γ receptor knockout mice. Am J Pathol 158: 2117-2125, 2001.
2. Egan JJ. New treatments for pulmonary fibrosis? Lancet 354: 1839-1840, 1999.
3. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, and Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50: 1234-1239, 1995.
4. King TE, Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr, Flint A, Thurlbeck W, and Cherniack RM. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164: 1025-1032, 2001.
5. Lok SS, Haider Y, Howell D, Stewart JP, Hasleton PS, Carroll KB, and Egan JJ. Murine γ herpes virus, a co-factor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J 20: 1228-1232, 2002.
6. Lung ML, Lam WK, So SY, Lam WP, Chan KH, and Ng MH. Evidence that respiratory tract is a major reservoir for epstein barr virus. Lancet 1: 889-892, 1985.
7. Mora AL, Woods CR, Garcia A, Xu J, Rojas M, Speck SH, Roman J, Brigham KL, and Stencenko AA. Lung infection with γ-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 289: L711-L721, 2005.
8. Raghu G, Brown K, Bradford W, Starko K, Noble PW, Schwartz DA, and King TE. Idiopathic Pulmonary Fibrosis Study Group. A placebo-controlled trial of interferon γ-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 350: 125-133, 2004.
9. Selam M, King TE, and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypothesis about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151, 2001.
10. Stewart JP, Egan JJ, Ross AJ, Kelly BG, Lok SS, Hasleton PS, and Woodcock AA. The detection of Epstein Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 159: 1336-1341, 1999.
11. Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, Brigham KL, Oates JA Jr, Loyd JE, and Stecenko AA. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 41: 2633-2640, 2003.
12. Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, and Miura K. Involvement of Epstein Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 55: 958-961, 2000.
13. Wallace WA, Ramage EA, Lamb D, and Howie SE. A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 101: 436-441, 1995.
14. Ziesche R, Hofbauer E, Wittmann K, Petkov V, and Block LH. A preliminary study of long term treatment with interferon γ-1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 341: 1264-1269, 1999.